Relia Biotech

ReLIA Biotech is a point-of-care testing (POCT) manufacturer with research and development center located in Silicon Valley, California. Under the guidance of Dr. Willian J. Rutter, our company’s founder, ReLIA has adhered to a diligent attitude towards research. We mold modern developments into technological advancement/systems, which promote rapid diagnostic services and improve the health and wellbeing of patients whilst simultaneously reducing medical costs. Currently, ReLIA Biotech focuses on two platforms of rapid diagnostic tests: 1. Multi-functional immunoassay platform (test kits + LFT readers) 2. Immunofluorescence detection platform (test kits + FIA readers) Both of these platforms cover the detection of biomarkers for cardiovascular, inflammation, autoimmune and other infectious disease, etc. Currently, ReLIA Biotech holds its Asian Pacific headquarters at the Shekou Free Trade Zone, Shenzhen, as well as large scale production and R&D centers in Shenzhen and Jiangsu.